戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  transgenic for the SARS-CoV receptor (human angiotensin-converting enzyme 2).
2 n system, angiotensin-converting enzyme, and angiotensin-converting enzyme 2.
3 e developed transgenic mice expressing human angiotensin-converting enzyme 2, a functional receptor f
4 tudies revealed a preferential expression of angiotensin-converting enzyme 2 (ACE-2), the functional
5                                              Angiotensin converting enzyme 2 (ACE2) is a negative reg
6                                              Angiotensin converting enzyme 2 (ACE2), the receptor for
7           Recently, a new member of the RAS, angiotensin converting enzyme 2 (ACE2), was discovered.
8 ns of SARS-S with the receptor for SARS-CoV, angiotensin converting enzyme 2 (ACE2); (ii) SSAA09E1 {[
9                                              Angiotensin-converting enzyme 2 (ACE2 or ACEH) is a nove
10                                              Angiotensin-converting enzyme 2 (ACE2) and its product,
11 is the only group I coronavirus known to use angiotensin-converting enzyme 2 (ACE2) as its receptor.
12                           The virus utilizes angiotensin-converting enzyme 2 (ACE2) as the primary re
13                                              Angiotensin-converting enzyme 2 (ACE2) expression has be
14  the ligand and key binding-site residues of angiotensin-converting enzyme 2 (ACE2) from its homologu
15                                              Angiotensin-converting enzyme 2 (ACE2) has emerged as a
16                                              Angiotensin-converting enzyme 2 (ACE2) is a cellular rec
17                                        Human angiotensin-converting enzyme 2 (ACE2) is a functional r
18                                              Angiotensin-converting enzyme 2 (ACE2) is a functional r
19                                              Angiotensin-converting enzyme 2 (ACE2) is a receptor for
20     The membrane-associated carboxypeptidase angiotensin-converting enzyme 2 (ACE2) is an essential r
21                                              Angiotensin-converting enzyme 2 (ACE2) is an integral me
22 ent study showed that directed expression of angiotensin-converting enzyme 2 (ACE2) on cells previous
23       However, while SARS-CoV uses the human angiotensin-converting enzyme 2 (ACE2) receptor for cell
24 n S likely increase recognition of the mouse angiotensin-converting enzyme 2 (ACE2) receptor not only
25 oprotein (S400-600), which overlaps with the angiotensin-converting enzyme 2 (ACE2) receptor-binding
26 by adipocytes, can be catabolized by adipose angiotensin-converting enzyme 2 (ACE2) to form Ang(1-7).
27 ry syndrome (SARS-CoV) utilizes the receptor angiotensin-converting enzyme 2 (ACE2) to infect cells.
28                    With the discovery of the angiotensin-converting enzyme 2 (ACE2), a protective axi
29                                              Angiotensin-converting enzyme 2 (ACE2), a recently ident
30 l host binding via the cell surface receptor angiotensin-converting enzyme 2 (ACE2), as well as the s
31 mploy the same receptor for host cell entry, angiotensin-converting enzyme 2 (ACE2), but it is largel
32         Here we identify a metallopeptidase, angiotensin-converting enzyme 2 (ACE2), isolated from SA
33         Expression of the SARS-CoV receptor, angiotensin-converting enzyme 2 (ACE2), resulted in SARS
34 demic in 2002 and 2003, binds to a receptor, angiotensin-converting enzyme 2 (ACE2), through the rece
35  interface between the RBD and its receptor, angiotensin-converting enzyme 2 (ACE2), to assess their
36  gaining binding affinity for human receptor angiotensin-converting enzyme 2 (ACE2).
37 acute respiratory syndrome CoV (SARS) CoV is angiotensin-converting enzyme 2 (ACE2).
38 a viral spike protein and its host receptor, angiotensin-converting enzyme 2 (ACE2).
39 attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2).
40 the S glycoprotein and the cellular receptor angiotensin-converting enzyme 2 (ACE2).
41 n and those expressing the SARS-CoV receptor angiotensin-converting enzyme 2 (ACE2).
42 (SARS) infects cells expressing the receptor angiotensin-converting enzyme 2 (ACE2).
43 ive arm of the renin angiotensin system, the angiotensin-converting enzyme 2 (ACE2)/angiotensin-(1-7)
44                                              Angiotensin-converting enzyme-2 (ACE2) is a critical reg
45                                              Angiotensin-converting enzyme-2 (ACE2) is a negative reg
46                In this paper, we report that angiotensin-converting enzyme-2 (ACE2) protected against
47                                              Angiotensin-converting-enzyme-2 (ACE2) has been describe
48   No changes in bronchoalveolar lavage fluid angiotensin-converting enzyme 2 activity were found.
49                                          The angiotensin-converting enzyme 2 and angiotensin-(1-7) (A
50               The conversion is catalyzed by angiotensin-converting enzyme 2 and other enzymes that s
51 on with enhanced BP, decreased expression of angiotensin converting enzyme 2, and increased expressio
52 eptapeptide generated by catalytic action of angiotensin-converting enzyme-2 angiotensin A or directl
53 ) exchanger 3, agonists of components of the angiotensin-converting enzyme 2/angiotensin(1-7)/Mas rec
54 protein with approximately 50% homology with angiotensin converting enzyme 2, but without a catalytic
55 BD, infected cells expressing human receptor angiotensin-converting enzyme 2, but with 90 to 95% less
56                                       Unlike angiotensin-converting enzyme 2, collectrin lacks any ca
57 part, could be attributable to a decrease in angiotensin-converting enzyme 2 expression observed in H
58 g their affinity for a viral receptor, human angiotensin-converting enzyme 2 (hACE-2), and their sens
59 at binds to its receptor glycoprotein, human angiotensin converting enzyme 2 (hACE2), and mediates vi
60  complexed with their common receptor, human angiotensin-converting enzyme 2 (hACE2), and proposed th
61 d that transgenic (Tg) mice expressing human angiotensin-converting enzyme 2 (hACE2), the receptor fo
62 ce that express the SARS-CoV receptor (human angiotensin-converting enzyme 2 [hACE2]) in airway and o
63 essing a functional SARS-CoV receptor (human angiotensin-converting enzyme 2) in a dose-dependent man
64                                              Angiotensin-converting enzyme 2 is the functional recept
65  was lower in fetal growth restriction in an angiotensin-converting enzyme 2 knockout mouse model cha
66                                        Since angiotensin-converting enzyme 2 metabolizes angiotensin
67 ght to determine whether circulating soluble angiotensin-converting enzyme 2 (sACE2) is increased in
68 renin-angiotensin system and is a homolog of angiotensin-converting enzyme 2, sharing approximately 5
69 mAbs significantly blocked RBD-Fc binding to angiotensin-converting enzyme 2, suggesting that their e
70                       Expression of mRNA for angiotensin converting enzyme 2, the SARS-CoV receptor,
71 omain (RBD), which mediates virus binding to angiotensin-converting enzyme 2, the functional receptor
72                        Recently, recombinant angiotensin-converting enzyme 2 was shown to protect mic

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。